Abstract
Neonatal sepsis is often lethal and results in considerable long-term morbidity among survivors if not treated adequately and expeditiously. It can be categorized into two somewhat separate syndromes based on the age of onset: early-onset and late-onset sepsis. Infants acquire harmful microorganisms that are prevalent in their surroundings, including the microbiota of their caretakers. The combination of invasive procedures frequently performed in the NICU significantly elevates the risk of sepsis in neonates.
This study sought to ascertain the incidence of positive blood cultures and delineate the discovered organisms along with their corresponding antibiotic susceptibility patterns in the NICU of a tertiary hospital. This was a prospective descriptive research encompassing all newborns with positive sepsis cultures admitted to the NICU at Baghdad Teaching Hospital, Iraq, from January 1, 2024, to November 30, 2024.
Throughout the trial duration, a total of 980 newborns were admitted to the facility. Ninety infants with positive blood cultures were documented, yielding an incidence rate of 9.2%. Among these, 75.6% experienced early-onset sepsis, whereas 24.4% experienced late-onset sepsis. Gram-positive bacteria constituted 32.2%, but gram-negative bacteria were more prevalent at 67.8%, with Acinetobacter being the predominant species. In the 90 sepsis cases, gram-negative bacterial isolates were more prevalent in both early-onset (63.2%) and late-onset (81.8%) instances. The frequency distribution of bacterial growth types and their antibiotic resistance indicated that Acinetobacter exhibited the lowest sensitivity to antibiotics at 36.4%. The case-fatality rates were 36.4% for Acinetobacter, 17.2% for Staphylococcus spp., 66.7% for E. coli, 50.0% for Serratia marcescens, and 0.0% for Klebsiella. Acinetobacter isolates were substantially correlated with both early and late onset of sepsis, an elevated incidence of comorbidities, and increased fatality rates (P-value < 0.05).
This study concludes that early-onset sepsis is more prevalent, with nosocomial infections, particularly gram-negative bacteria, being the predominant kind of sepsis. The majority of clinically significant organisms exhibited resistance to the primary antibiotic regimen.
References
Joanne E. EmbreeNora, I. Alfattoh. Infections in the Newborn. Mhairi G. MacDonald, Mary M. K. Seshia, editors. AVERY’S Neonatology. 17th ed. Lippincott Williams and Wilkins; 2015. P. 930-44.
Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151–61. doi: 10.1016/S0140-6736(12)60560-1.
Frank E. Postnatal Bacterial Infections. Richard J. Martin, Avroy A. Fanaroff, Michele C. Walsh, editors. Fanaroff and Martin’s Neonatal-Perinatal Medicine, 11th ed. Egyptian Knowledge; 2019. P. 789-48.
Singer M, Deutschman CS, Seymour CW, et al. The third International consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801–10. 10.1001/jama.2016.0287.
Kayange N, Kamugisha E, Mwizamholya DL, Jeremiah S, Mshana SE. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza- Tanzania. BMC Pediatr [serial online]. 2010December4;10(1):39. Available from: http://bmcpediatr.biomedcentral.com/articles/10.1186/1471-2431-10-39.
Wynn JL. Defining neonatal sepsis. Curr Opin Pediatr [serial online]. 2016April;28(2):135–140. Available from: https://journals.lww.com/co-pediatrics/Fulltext/2016/04000/Defining_neonatal_sepsis.3.aspx.
Fabien G. Eyal, Fayez Bany-Mohammed. Infectious Diseases. Gomella T. ,editors. GOMELLA’S NEONATOLOGY, 8th ed. United States; 2020. P.1115-146.
Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med 2018;6:223–30. 10.1016/S2213-2600(18)30063-8.
Coetzee M, Mbowane N, de Witt T. Neonatal sepsis: Highlighting the principles of diagnosis and management. S Afr J Child Health. 2017;11(2):99–103. doi: 10.7196/SAJCH.2017.v11i2.1244.
Hofer N, Zacharias E, Muller W, Resch B. Performance of the definitions of the systemic inflammatory response syndrome and sepsis in neonates. J Perinat Med. 2012;40(5):587–90. doi: 10.1515/jpm-2011-0308.
Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr [serial online]. 2015February1;61(1):1–13. Available from: https://academic.oup.com/tropej/article-lookup/doi/10.1093/tropej/fmu079.
Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am 2013;60:367–89.
Khassawneh M, Hayajneh WA, Kofahi H, Khader Y, Amarin Z, Daoud A. Diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6 and immunoglobulin M. Scand J Immunol 2007; 65: 171–175.
Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004; 51: 939–959.
Puopolo KM, Benitz WE, Zaoutis TE. Management of neonates born at ≥35 0/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142(6).
Puopolo KM, Benitz WE, Zaoutis TE. Management of neonates born at ≤34 6/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142(6).
Doronjski A, Barišić N, Stojanović V. Risk factors for neonatal sepsis and method for reduction of blood culture contamination. Malawi Med J [serial online]. 2015April24;27(1):20. Available from: http://www.ajol.info/index.php/mmj/article/view/116232.
Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis 2013; 13: 1057–98.
Cailes B, Vergnano S, Kortsalioudaki C, Heath P, Sharland M. The current and future roles of neonatal infection surveillance programmes in combating antimicrobial resistance. Early Hum Dev 2015; 91: 613–18.
Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect [serial online]. 2012March;18(3):268–281. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1198743X14616323.
Laxminarayan R., Matsoso P., Pant S., Brower C., Røttingen J.A., Klugman K., Davies S. Access to effective antimicrobials: A worldwide challenge. Lancet. 2016;387:168–175. doi: 10.1016/S0140-6736(15)00474-2.
Li G., Bielicki J.A., Ahmed AS MN U., Islam M.S., Berezin E.N., Gallacci C.B., Guinsburg R., da Silva Figueiredo C.E., Vieira R.S., Silva A.R., et al. Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: Insights from the NeoAMR network. Arch. Dis. Child. 2020;105:26–31. doi: 10.1136/archdischild-2019-316816.
Fleischmann C., Reichert F., Cassini A., Horner R., Harder T., Markwart R., Tröndle M., Savova Y., Kissoon N., Schlattmann P., et al. Global incidence and mortality of neonatal sepsis: A systematic review and meta-analysis. Arch. Dis. Child. 2021;106:745–752. doi: 10.1136/archdischild-2020-320217.
Wang J., Lv Y., Yang W., Zhao P., Yin C. Epidemiology and clinical characteristics of infection/colonization due to carbapenemase-producing Enterobacterale in neonatal patients. BMC Microbiol. 2022;22:177. doi: 10.1186/s12866-022-02585-z.
Sands K., Carvalho M.J., Portal E., Thomson K., Dyer C., Akpulu C., Andrews R., Ferreira A., Gillespie D., Hender T., et al. Characterization of antimicrobial-resistant Gram negative bacteria that cause neonatal sepsis in seven low and middle-income countries. Nat. Microbiol. 2021;6:512–523. doi: 10.1038/s41564-021-00870-7.
Thomson K.M., Dyer C., Liu F., Sands K., Portal E., Carvalho M.J., Barrell M., Boostrom I., Dunachie S., Farzana R., et al. Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: An international microbiology and drug evaluation prospective substudy (BARNARDS) Lancet Infect. Dis. 2021;21:1677–1688. doi: 10.1016/S1473-3099(21)00050-5.
Wei H., Hsu Y., Lin H., Hsieh T., Yen T., Su B., Hawny K. Multidrug-resistant Acinetobacter baumannii infection among neonates in a neonatal intensive care unit at a medical center in central Taiwan. Journal of Microbiology, Immunology and Infection Volume 48, Issue 5, October 2015, Pages 531-539. https://doi.org/10.1016/j.jmii.2014.08.025.
Chaurasia S., Sankar M., Agarwal R. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. Lancet Glob Health 2016; 4: e752–60.
Staaden Van H., Hendrick C., Spicer K. Bacteraemia and antibiotic sensitivity in a tertiary neonatal intensive care unit. S Afr J Infect Dis. 2021 Jan 5;36(1):195. doi: 10.4102/sajid.v36i1.195
Pokhrel B, Koirala T, Shah G, Joshi S, Baral P. Bacteriological profile and antibiotic susceptibility of neonatal sepsis in neonatal intensive care unit of a tertiary hospital in Nepal. BMC Pediatr [serial online]. 2018December27;18(1):208. Available from: https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-018-1176-x